1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. New York >
  6. Assembly Pharmaceuticals Acquires Ventrus Biosciences

M&A Deal Summary

Assembly Pharmaceuticals Acquires Ventrus Biosciences

On May 19, 2014, Assembly Pharmaceuticals acquired life science company Ventrus Biosciences

Acquisition Highlights
  • This is Assembly Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Assembly Pharmaceuticals’ 1st transaction in the United States.
  • This is Assembly Pharmaceuticals’ 1st transaction in New York.

M&A Deal Summary
Date 2014-05-19
Target Ventrus Biosciences
Sector Life Science
Buyer(s) Assembly Pharmaceuticals
Deal Type Merger
Advisor(s) Torreya Partners (Financial)

Target

Ventrus Biosciences

New York, New York, United States
Ventrus BioSciences, Inc. is a development-stage specialty pharmaceutical company currently focused on the development of gastrointestinal (GI) products, including infections of the GI system.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Assembly Pharmaceuticals

Bloomington, Indiana, United States
Category Company
Founded 2012
Sector Healthcare Services
DESCRIPTION

Assembly Pharmaceuticals is a virology-focused biopharmaceutical company with a discovery platform and programs based on proprietary Core Protein Allosteric Modulators (CpAMs) for the treatment of viral infections, starting with hepatitis B (HBV).

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2014 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal